|
|
||||||||
From The Wistar Institute of Anatomy and Biology, 36th Street at Spruce, Philadelphia, Pennsylvania 19104
Abstract
The H-2 gene complex controls the ability of mice to generate cytotoxic T cells to the SV40 tumor-associated specific antigen (TASA). Mice of six H-2 haplotypes (H-2b, d, f, k, q, and s) were challenged in vivo with syngeneic simian virus 40 (SV40)-transformed cells. By testing splenic lymphocytes in a 51Cr cytotoxic test, only H-2b mice were able to generate cytotoxic T cells specific for syngeneic SV40-transformed target cells. In contrast, immune lymphocytes from both H-2b and H-2k mice assayed after secondary in vitro restimulation lysed SV40-transformed target cells of appropriate H-2 genotype. Popliteal lymph node cells from H-2b, k, and d mice, immunized by footpad injection of SV40 and then incubated for 14 days in vitro before assay, are cytotoxic for syngeneic SV40-transformed cells. With this immunization protocol, H-2b mice respond to SV40 TASA in association with both the H-2 K and D locus-coded molecules, whereas H-2k mice respond to SV40 TASA in association with the H-2 K molecule only and H-2d mice respond to SV40 TASA in association with the H-2 D gene product. SV40 TASA-immune lymphocytes from various F1 (responder x nonresponder) mice were also unable to lyse syngeneic H-2Kd or H-2Dk SV40-transformed target cells. Inhibition of the response to SV40 TASA in association with H-2Dd is found when lymphocytes from SV40 TASA-immune F1 hybrid (H-2b x H-2d) or H-2 congenic recombinant (H-2KbDd) mice are analyzed. A dominant suppression or recessive helper mechanism is hypothesized to account for these results.
Footnotes
1 This work was supported in part by Public Health Service Research Grants CA 18470, CA 20833, and CA 17546 from the National Cancer Institute, and Research Career Award AI 00053 (B. B. K.) from the National Institute of Allergy and Infectious Diseases and by the American Cancer Society (PDT 26, IM-88).
2 Present address: Institute for Medical Microbiology, Johannes Gutenberg University, 6500 Mainz, West Germany.
3 Present address: Swiss Institute for Cancer Research, CH 1066 Epalinges, Lausanne, Switzerland.
This article has been cited by other articles:
![]() |
I. Tsunoda, L.-Q. Kuang, M. Kobayashi-Warren, and R. S. Fujinami Central Nervous System Pathology Caused by Autoreactive CD8+ T-Cell Clones following Virus Infection J. Virol., December 1, 2005; 79(23): 14640 - 14646. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tsunoda, L.-Q. Kuang, and R. S. Fujinami Induction of Autoreactive CD8+ Cytotoxic T Cells during Theiler's Murine Encephalomyelitis Virus Infection: Implications for Autoimmunity J. Virol., November 13, 2002; 76(24): 12834 - 12844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Satoi, K. Murata, M. Lechmann, E. Manickan, Z. Zhang, H. Wedemeyer, B. Rehermann, and T. J. Liang Genetic Immunization of Wild-Type and Hepatitis C Virus Transgenic Mice Reveals a Hierarchy of Cellular Immune Response and Tolerance Induction against Hepatitis C Virus Structural Proteins J. Virol., December 15, 2001; 75(24): 12121 - 12127. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Utermohlen, C. Schulze-Garg, G. Warnecke, R. Gugel, J. Lohler, and W. Deppert Simian Virus 40 Large-T-Antigen-Specific Rejection of mKSA Tumor Cells in BALB/c Mice Is Critically Dependent on both Strictly Tumor-Associated, Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ T Helper Cells J. Virol., November 15, 2001; 75(22): 10593 - 10602. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mylin, T. D. Schell, D. Roberts, M. Epler, A. Boesteanu, E. J. Collins, J. A. Frelinger, S. Joyce, and S. S. Tevethia Quantitation of CD8+ T-Lymphocyte Responses to Multiple Epitopes from Simian Virus 40 (SV40) Large T Antigen in C57BL/6 Mice Immunized with SV40, SV40 T-Antigen-Transformed Cells, or Vaccinia Virus Recombinants Expressing Full-Length T Antigen or Epitope Minigenes J. Virol., August 1, 2000; 74(15): 6922 - 6934. [Abstract] [Full Text] |
||||
![]() |
Y. C. Xie, C. Hwang, W. Overwijk, Z. Zeng, M. H. Eng, J. J. Mule, M. J. Imperiale, N. P. Restifo, and M. G. Sanda Induction of Tumor Antigen-Specific Immunity In Vivo by a Novel Vaccinia Vector Encoding Safety-Modified Simian Virus 40 T Antigen J Natl Cancer Inst, January 20, 1999; 91(2): 169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chiu, J. Jayawardena, A. Weiss, D. Lee, S.-H. Park, A. Dautry-Varsat, and A. Bendelac Distinct Subsets of CD1d-restricted T Cells Recognize Self-antigens Loaded in Different Cellular Compartments J. Exp. Med., January 4, 1999; 189(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jooss, H. C. J. Ertl, and J. M. Wilson Cytotoxic T-Lymphocyte Target Proteins and Their Major Histocompatibility Complex Class I Restriction in Response to Adenovirus Vectors Delivered to Mouse Liver J. Virol., April 1, 1998; 72(4): 2945 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Park, J. H. Roark, and A. Bendelac Tissue-Specific Recognition of Mouse CD1 Molecules J. Immunol., April 1, 1998; 160(7): 3128 - 3134. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Minter, M. A. Ferry, J. E. Rectenwald, F. R. Bahjat, A. Oberholzer, C. Oberholzer, D. La Face, V. Tsai, C. M. I. Ahmed, B. Hutchins, et al. Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy PNAS, January 2, 2001; 98(1): 277 - 282. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |